Latest mechanical ventilation Stories
WARRINGTON, Pa., March 6, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that the United States Food and Drug Administration (FDA) has approved SURFAXIN (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS. SURFAXIN is the first synthetic, peptide-containing surfactant approved for use...
HAMPTON, N.J., Feb. 27, 2012 /PRNewswire/ -- Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today announced that it has enrolled the last patient into its Pivotal Phase III trial investigating the use of inhaled nitric oxide (iNO) in premature infants with bronchopulmonary dysplasia (BPD). The trial, which commenced in December 2009, enrolled its last patient six weeks ahead of schedule....
Fever control using external cooling in sedated patients with septic shock is safe and decreases vasopressor requirements and early mortality, according to a new study from researchers in France. "The benefits and risks of fever control in patients with severe sepsis remains a matter of controversy," said lead author Frédérique Schortgen, MD, PhD, of the Henri Mondor Hospital in Créteil, France. "In our study, external cooling to achieve normothermia in patients with septic shock was...
WARRINGTON, Pa., Feb. 8, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that it has entered into a definitive agreement with Lacey Manufacturing, a unit of Precision Engineered Products, LLC to manufacture and supply product for the commercial introduction of AFECTAIR®. AFECTAIR was recently cleared for commercialization in the United States and...
WARRINGTON, Pa., Feb. 2, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced AFECTAIR® is now registered with the Food and Drug Administration (FDA) and is cleared to be marketed in the United States. AFECTAIR is a proprietary patient interface technology that simplifies delivery of aerosolized medications to patients requiring ventilator support....
Extracorporeal membrane oxygenation (ECMO) support in awake, non-intubated patients may be an effective strategy for bridging patients to lung transplantation, according to a new study from Germany. "As waiting times for donor organs continue to increase, so does the need for bridging strategies for patients with end-stage lung disease awaiting transplantation," said Marius M. Hoeper, MD, professor of medicine at the Hannover Medical School in Hannover, Germany. "Our study shows that ECMO...
CHICAGO and BOSTON, Dec. 13, 2011 Real time monitoring of the adequacy of ventilation (i.e. how much carbon dioxide a patient breathes out) could save patients' lives, recent research suggests. Just ask Lenore Alexander, whose daughter Leah had elective surgery for pectus carinatum, a fairly common condition where the sternum protrudes forward caused by an overgrowth of cartilage. [For the YouTube video by The Empowered Patient Coalition on Leah and other children who died in...
SAN DIEGO, Nov. 4, 2011 /PRNewswire/ -- CareFusion today announced the CareFusion Ventilation System, combining its industry leading ventilators with new interoperability and analytics software to better address clinical and operational challenges in patient care. The CareFusion Ventilation System includes the company's AVEA®, VELA® and EnVeTM ventilators and adds two new applications: CareFusion Respiratory Documentation Application: A handheld, positive patient ID application that...
American ALDES is now working with the top hotel chains to implement highly effective strategies to save energy at existing properties by installing devices that automatically regulate ventilation systems to save energy and provide good indoor air quality. Bradenton, FL (PRWEB) October 28, 2011 American ALDES is now working with the top hotel chains to implement highly effective strategies to save energy at existing properties by installing devices that automatically regulate ventilation...
STEVENSVILLE, Md., Oct. 27, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today receiving FDA clearance for Precision Flow® Heliox, a high flow humidification system designed specifically for use with blended helium oxygen gas mixtures (Heliox). The product is part of Vapotherm's High Flow Specialty Gas Program for optimal conditioning of breathing gases. Heliox is used in a variety of respiratory applications such as upper airway obstruction, asthma, croup and COPD. "We are...
